TNW | Investors-funding
Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports
Bloomberg says the Google DeepMind spinout is in talks to raise roughly $5bn. The Isomorphic Labs valuation would be about $50bn, though it has no drug in human trials yet.
By TNW | Investors-funding
Excerpt shared by Lazyfounder
·Excerpt
Max Jaderberg, president of Isomorphic Labs, speaking at TED.
Isomorphic Labs, the drug discovery company spun out of Google DeepMind, is in talks to raise about $5bn, Bloomberg reported on Wednesday. The round would put the Isomorphic Labs valuation at about $50bn, according to people familiar with the matter.
The…
Courtesy
This story was originally published by TNW | Investors-funding. All rights belong to the original publisher.
Read the original on thenextweb.com ↗